IL Therapeutics
Industry | Biotechnology |
---|---|
Headquarters | 105E ñ 111 Research Drive, Saskatoon, SK, Canada |
IL Therapeutics Inc. was previously owned by Western Life Sciences Venture Fund LP (“Western Life Sciences”) and in 2006 its shares were purchased by Pacgen Biopharmaceuticals Corporation (“Pacgen”).[1]
History
Saskatchewan Research Council operates a bio-processing laboratory which facilitated biomedical research. IL Therapeutics was developed from research first begun at the Western College of Veterinary Medicine
Pharmaceuticals
Currently IL Therapeutics is working on a drug candidate, IL-8(3-73)K11R/G31P (“PAC-G31P”) for relief of Acute Respiratory Distress Syndrome (ARDS)[2] The Saskatchewan Research council, SRC also assisted with the funding of this project through the Agriculture Development Fund - SRC Industry Venture Fund.[3] The successful progression of G31PRecently the University of Saskatchewan Industry Liaison Office (ILO) decided to commercialize a commercialize this new drug treatment.[4] This research has been sponsored by a $3 million boost from the Western Life Sciences Venture Fund (WLS)[4]
See also
- Biotechnology
- List of biotechnology companies
- Innovation Place Research Park
- University of Saskatchewan
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 4.0 4.1 Lua error in package.lua at line 80: module 'strict' not found. Cite error: Invalid
<ref>
tag; name "UofS" defined multiple times with different content
External links
- University of Saskatchewan Research - Discovery @ U of S: May 24, 2006
- AgBiotech Bulletin
- Europe and GMOs: the dance continues In this issue:
- U of S News Releases: November 2004 Archives
- Untitles
- Western College of Veterinary Medicine
<templatestyles src="Asbox/styles.css"></templatestyles>
<templatestyles src="Asbox/styles.css"></templatestyles>